Activity Overview
The 25th Annual International Congress on the Future of Breast Cancer® West provides clinicians with cutting-edge updates on recent advances in the treatment of breast cancer, from preclinical breakthroughs to changes in clinical treatment paradigms. Novel agents and improved regimens, coupled with more in-depth molecular and phenotypic subtyping, are driving the future of breast cancer therapy. This dynamic program focuses on the practical implications of emerging data for patient care in the clinic. Recent data and their clinical impact are highlighted throughout the program, with expert perspectives on how to apply the evidence to individualize therapy for patients with breast cancer. Current areas of controversy or uncertainty are also debated, with discussions of ongoing clinical trials and investigational approaches designed to address these questions.
This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other health care professionals to learn from international leaders in the field of breast cancer to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.
This educational activity is an archive of the live presentation held on July 17-18, 2026.
Target Audience
This educational activity is intended for medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer may also participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Integrate genomic and molecular biomarker findings into individualized treatment strategies for patients with early-stage and metastatic breast cancer
- Formulate multidisciplinary locoregional management strategies incorporating contemporary imaging, surgical, and radiation approaches
- Evaluate emerging data from key clinical trials and their implications for the management of early-stage and advanced/metastatic breast cancer
- Apply current evidence and guideline recommendations to develop stage-specific, personalized treatment plans for patients with breast cancer
- Implement evidence-based strategies to prevent and manage treatment-related adverse events in breast cancer care

Sara A. Hurvitz, MD, FACP
Professor of Medicine
Smith Family Endowed Chair in Women’s Health
Head, Division of Hematology and Oncology
Senior Vice President, Clinical Research Division
Department of Medicine
UW Medicine
Fred Hutch Cancer Center
Seattle, WA

Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Director, Breast Cancer Research Program
Texas Oncology
US Oncology
Dallas, TX
Faculty disclosures are available in the document linked here.
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.
This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.
The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.
This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here



